Impact of renal function on the underlying pathophysiology of coronary plaque composition in patients with type 2 diabetes mellitus

Table 2 Variables measured by the continuous glucose monitoring system

Variables	Overall (n = 71)	Group 1 (n = 40)	Group 2 (n = 31)	p value
Maximum blood glucose, mg/dl	274.6 ± 58.2	262.6 ± 49.9	290.2 ± 64.9	0.046
Minimum blood glucose, mg/dl	71.0 ± 24.7	71.1 ± 21.2	70.9 ± 29.0	0.566
Mean blood glucose, mg/dl	151.3 ± 35.8	145.0 ± 29.5	159.6 ± 41.6	0.154
MAGE, mg/dl	78.9 ± 24.9	75.2 ± 22.1	83.6 ± 27.7	0.242
Time in Hyperglycemia, %	9.6 (3.8–25.2)	8.8 (3.2–13.8)	12.7 (4.4–30.8)	0.344
Time in Hypoglycemia, %	0 (0–2.2)	0 (0–1.5)	0 (0–2.6)	0.591
Time in hyperglycemia, hours	10.6 (3.1–27.0)	8.8 (2.3–15.4)	15.2 (5.3–37.0)	0.178
Time in hypoglycemia, hours	0 (0–2.7)	0 (0–1.6)	0 (0–3.1)	0.599

Values are mean ± SD (%). Group 1: ≥ 60 mL/min/1.73 m², Group 2: < 60 mL/min/1.73 m². p values for Group 1 vs. Group 2
Time in hyperglycemia was defined as the time when blood glucose levels were equal to or greater than 200 mg/dl. Time in hypoglycemia was defined as the time when blood glucose levels were under 70 mg/dl. MAGE, mean amplitude of glycemic excursion

ISSN: 1475-2840